GeneHealth - Your precision medicine

Ileus

Disease Details

Family Health Simplified

Buy Membership

Description: Ileus is a temporary and often painful lack of movement in the intestines that prevents the passage of food and waste, leading to a buildup of material.
Type: Ileus is not typically classified by a specific genetic transmission type because it is generally related to non-genetic factors. Ileus refers to a temporary stoppage of the normal bowel movement, often caused by abdominal surgery, infections, medications, or other medical conditions affecting the intestines. It is not inherited or passed down through families via genetic transmission.
Signs And Symptoms: Symptoms of ileus include, but are not limited to:
moderate to severe, diffuse abdominal pain
constipation
abdominal distension
nausea/vomiting, especially after meals
vomiting of bilious fluid (green or yellowish-green in colour)
flatulence and/or lack of bowel movement
excessive belching
Prognosis: The prognosis for ileus depends on the underlying cause, promptness of treatment, and overall health of the patient. If treated promptly and effectively, the outlook is generally good, and normal bowel function often returns. Prolonged or untreated ileus can lead to complications such as bowel perforation, infection, or sepsis, which can worsen the prognosis. Each case should be evaluated individually, and close medical monitoring is essential.
Onset: Ileus is characterized by a disruption of the normal propulsive ability of the gastrointestinal tract. The onset of ileus can be acute, often following abdominal surgery, infection, certain medications, or underlying medical conditions. The condition may present with symptoms such as abdominal pain, bloating, nausea, vomiting, and an absence of bowel movements or flatulence.
Prevalence: Ileus is a condition characterized by a temporary cessation of normal bowel movements, often due to surgery, medications, or other underlying health issues. However, there are no specific estimates for the prevalence of ileus. The incidence can vary widely depending on the patient population studied and the clinical setting, particularly because ileus frequently occurs as a postoperative complication.
Epidemiology: Ileus, a condition characterized by a lack of movement in the intestines leading to a blockage, does not have nan values in its data sets. Here’s some relevant epidemiological information:

- **Incidence**: The incidence of postoperative ileus, a common type, is estimated to occur in around 10-30% of patients who undergo abdominal surgery.
- **Risk Factors**: Common risk factors for ileus include abdominal or pelvic surgeries, infections, electrolyte imbalances, and use of certain medications (especially opioids).
- **Population Affected**: It primarily affects hospitalized patients, particularly those recovering from surgery or who have certain medical conditions leading to reduced gastric motility.
- **Geographic Distribution**: There is no significant geographic predisposition, although healthcare system differences might influence the diagnosis and management rates.

Ileus impacts a broad demographic but is particularly prevalent in surgical and critically ill patients.
Intractability: Ileus is generally not intractable. It is often a temporary and reversible condition that can resolve with medical management, including bowel rest, intravenous fluids, and addressing the underlying cause. However, some cases may require more intensive treatment or surgery if symptoms persist or complications arise.
Disease Severity: Ileus is a temporary and often reversible obstruction of the intestines due to a lack of peristalsis. The severity of ileus can range from mild to severe and typically depends on factors such as the underlying cause, duration, and the patient's overall health condition. Mild cases may resolve with conservative treatment like bowel rest and fluids, while severe cases can result in significant complications and may require surgical intervention. "Nan" commonly means "not a number," but without additional context, it's presumed to be irrelevant here.
Healthcare Professionals: Disease Ontology ID - DOID:8440
Pathophysiology: Ileus is characterized by a disruption of the normal propulsive ability of the gastrointestinal tract. The pathophysiology involves impaired bowel motility, which can be due to a variety of factors:

1. **Neurogenic factors**: Postoperative conditions, especially after abdominal surgeries, can result in temporary dysregulation of the gastrointestinal nervous system, hampering peristalsis.
2. **Inflammatory responses**: Conditions like peritonitis, pancreatitis, or severe infections can lead to ileus by causing inflammation of the bowel.
3. **Electrolyte imbalances**: Disturbances in electrolytes, such as hypokalemia, can impair smooth muscle function and lead to ileus.
4. **Medications**: Drugs, particularly opioids, anticholinergics, and certain anesthetics, can decrease bowel motility.
5. **Systemic illness**: Severe systemic illnesses, trauma, or sepsis can cause physiological stress that contributes to ileus.

Resolving ileus often involves addressing the underlying cause, providing supportive care, and sometimes using pharmacologic interventions to stimulate bowel movement.
Carrier Status: Ileus does not involve a carrier status because it is not an infectious disease or a genetic condition with carriers. Instead, ileus is a temporary and often reversible lack of movement in the intestines that can result in a blockage. It can be caused by various factors, including surgery, infections, medications, and certain illnesses.
Mechanism: Ileus is a disruption of the normal propulsive ability of the gastrointestinal tract. It can be broadly categorized into mechanical obstruction and non-mechanical (functional) obstruction.

**Mechanism:**
In ileus, the primary problem is the lack of coordinated peristalsis, which leads to stasis of bowel contents. This can occur due to:
- Post-surgical inflammation or handling of the intestines.
- Electrolyte imbalances such as hypokalemia.
- Use of certain medications like opioids.
- Infectious or inflammatory conditions affecting the gut.

**Molecular Mechanisms:**
1. **Inflammatory Mediators:**
- Surgery or trauma can activate the immune response, releasing cytokines such as IL-6, TNF-alpha, and IL-1beta. These cytokines interfere with normal enteric nervous system functions, impairing peristalsis.

2. **Neurogenic Factors:**
- Disruption to the autonomic nervous system balance (sympathetic/parasympathetic control) can impair bowel motility. Increased sympathetic activity or reduced parasympathetic activity can inhibit peristalsis.

3. **Electrolyte Disturbances:**
- Potassium, calcium, and magnesium ions play critical roles in muscle contraction and neuronal activity. An imbalance can disrupt intestinal smooth muscle function and neuronal signaling.

4. **Pharmacologic Agents:**
- Drugs like opioids bind to mu-receptors in the gastrointestinal tract, inhibiting acetylcholine release, which is essential for smooth muscle contraction in the intestines.

Understanding these mechanisms provides insight into both the broad and detailed processes that can contribute to the development of an ileus.
Treatment: Traditionally, nothing by mouth was considered to be mandatory in all cases, but gentle feeding by enteral feeding tube may help to restore motility by triggering the gut's normal feedback signals, so this is the recommended management initially. When the patient has severe, persistent signs that motility is completely disrupted, nasogastric suction and parenteral nutrition may be required until passage is restored. In such cases, continuing aggressive enteral feeding causes a risk of perforating the gut.
Several options are available in the case of paralytic ileus. Most treatment is supportive. If caused by medication, the offending agent is discontinued or reduced. Bowel movements may be stimulated by prescribing lactulose, erythromycin or, in severe cases that are thought to have a neurological component (such as Ogilvie's syndrome), neostigmine. There is also evidence from a systematic review of randomized controlled trials that chewing gum, as a form of 'sham feeding', may stimulate gastrointestinal motility in the post-operative period and reduce the duration of postoperative ileus.If possible the underlying cause is corrected (e.g. replace electrolytes).
Compassionate Use Treatment: Ileus, a condition characterized by a lack of movement in the intestines that can lead to a buildup and potential blockage, may be treated using several approaches under compassionate use, off-label, or experimental settings:

1. **Neostigmine**: An acetylcholinesterase inhibitor, neostigmine is sometimes used off-label to stimulate bowel movements in patients with ileus, particularly in cases of acute colonic pseudo-obstruction (Ogilvie syndrome).

2. **Alvimopan**: This peripherally acting μ-opioid receptor antagonist is approved for accelerating gastrointestinal recovery after bowel resection surgery and has been used off-label for treating postoperative ileus.

3. **Entereg (alvimopan)**: While approved for short-term use to help restore bowel function after surgery, its application can sometimes extend beyond those parameters on a compassionate use basis.

4. **Erythromycin**: Known primarily as an antibiotic, erythromycin also has prokinetic properties and has been used off-label to enhance gastrointestinal motility.

5. **Methylnaltrexone**: A μ-opioid receptor antagonist used primarily for opioid-induced constipation might be explored in experimental settings for ileus related to opioid use.

6. **Acupuncture**: Though more alternative, acupuncture has been studied experimentally for its potential in stimulating bowel motility and could be considered under compassionate use.

7. **Probiotic Therapy**: Certain probiotics are under investigation for their role in gut health and motility and might be considered in experimental trials for ileus.

These treatments should be considered carefully, typically under a physician's guidance and within the context of a healthcare setting, particularly when conventional treatments have failed or are not applicable.
Lifestyle Recommendations: Lifestyle recommendations for managing and preventing ileus include:

1. **Dietary Adjustments**: Gradually introduce high-fiber foods and maintain a balanced diet to promote healthy bowel movements. Avoid heavy, fatty, and overly processed foods.

2. **Hydration**: Drink plenty of fluids, particularly water, to help keep the digestive system moving smoothly.

3. **Physical Activity**: Engage in regular exercise, such as walking, to stimulate bowel activity and enhance gastrointestinal motility.

4. **Meal Patterns**: Eat smaller, more frequent meals throughout the day instead of large, heavy meals.

5. **Post-Surgical Care**: Follow post-operative care instructions carefully, including any dietary restrictions and activity recommendations from your healthcare provider.

6. **Avoid Certain Medications**: Use medications known to affect bowel function (e.g., narcotics) cautiously and under medical supervision to prevent or alleviate disruptions in bowel motility.

7. **Stress Management**: Practice stress-relieving techniques such as yoga, meditation, or deep breathing exercises to reduce the potential impact of stress on the digestive system.

8. **Monitoring Symptoms**: Be aware of signs of bowel obstruction or delayed emptying, and seek prompt medical attention if symptoms worsen or new symptoms appear.

These measures can help maintain normal bowel function and reduce the risk of ileus.
Medication: Ileus is a condition characterized by a lack of movement in the intestines that leads to a buildup and potential blockage of food material. Medications that may be used to manage or treat ileus include:

1. **Prokinetics**: Drugs like metoclopramide or erythromycin can stimulate gut motility.
2. **Electrolyte Replacement**: Correcting electrolyte imbalances with intravenous fluids can help restore normal intestinal function.
3. **Analgesics**: Pain management, ideally avoiding opiates which can worsen ileus.
4. **Anti-emetics**: Medications like ondansetron to control nausea and vomiting.

The choice of medication should be guided by the underlying cause of ileus and the patient’s overall condition.
Repurposable Drugs: For the treatment of ileus, some repurposable drugs include:

1. **Metoclopramide**: Initially used as an antiemetic and prokinetic agent, it can enhance gastrointestinal motility.
2. **Neostigmine**: Originally used for treating myasthenia gravis, it can be used to stimulate bowel movements in cases of colonic ileus.
3. **Erythromycin**: An antibiotic that has prokinetic properties, it can be used off-label to stimulate motility in the gastrointestinal tract.

These drugs, while repurposed, should be administered under medical supervision to ensure they are appropriately indicated for the patient's specific condition.
Metabolites: For ileus, metabolites can include a variety of substances that accumulate due to disrupted gastrointestinal function. These may include:

1. **Lactate**: Increased levels due to hypoperfusion and anaerobic metabolism.
2. **Electrolytes**: Imbalances such as hypokalemia or hyponatremia.
3. **Urea and Creatinine**: Elevated in cases of dehydration and reduced kidney function.

Please note that the specific profile of metabolites can vary depending on the underlying cause and severity of the ileus.
Nutraceuticals: For ileus, there are no specific nutraceuticals established as effective treatments. Management typically involves supportive care such as intravenous fluids, electrolyte correction, bowel rest, and sometimes nasogastric decompression. Consultation with a healthcare provider is essential for appropriate treatment.
Peptides: Ileus is a condition characterized by a lack of movement in the intestines that leads to a buildup and potential blockage of food material. Peptides such as ghrelin and its analogs have been studied for their potential to stimulate gastrointestinal motility, which may help manage ileus. Nanotechnology applications (nan) are emerging in medical research for drug delivery systems that could potentially target and treat ileus with greater precision and efficacy.